ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,306,233 | +127.7% | 501,355 | +401.4% | 0.02% | +60.0% |
| Q4 2022 | $1,013,000 | -87.3% | 100,000 | -86.6% | 0.01% | -89.0% |
| Q2 2022 | $7,952,000 | -52.9% | 746,652 | -56.9% | 0.09% | -51.1% |
| Q1 2022 | $16,885,000 | -16.7% | 1,731,812 | +22.2% | 0.19% | -20.2% |
| Q4 2021 | $20,268,000 | +1308.5% | 1,417,363 | +1873.5% | 0.23% | +1194.4% |
| Q3 2021 | $1,439,000 | -70.9% | 71,820 | -68.1% | 0.02% | -68.4% |
| Q2 2021 | $4,950,000 | -27.1% | 225,000 | +12.5% | 0.06% | -35.2% |
| Q1 2021 | $6,792,000 | -32.5% | 200,000 | -20.0% | 0.09% | -38.0% |
| Q4 2020 | $10,060,000 | – | 250,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |